Indian Journal of Urology Users online:644  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
CASE REPORT
Year : 2021  |  Volume : 37  |  Issue : 3  |  Page : 270-273

COVID-19 and fatal renal mucormycosis: Contributory or coincidental?


1 Department of Urology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India
2 Department of Microbiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India

Correspondence Address:
Rahul Jena
Department of Urology, All India Institute of Medical Sciences, Jodhpur, Rajasthan
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/iju.iju_197_21

Rights and Permissions

Association of mucormycosis with COVID-19 disease is emerging as a matter of concern, with multiple reports of rhino-cerebral-orbital and pulmonary involvement. The association of isolated renal mucormycosis in a patient with a history of COVID-19 infection is unknown. The immune dysregulation associated with COVID, along with the use of steroids, mechanical ventilation, and interleukin-6-directed therapies, predisposes to the development of mucormycosis. We report a rare case of primary renal mucormycosis in a young male following recovery from COVID-19. The unusual mode of presentation, rapidly progressive disease course, and the ensuing dilemmas in diagnosis and treatment merit critical analysis.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3085    
    Printed94    
    Emailed0    
    PDF Downloaded250    
    Comments [Add]    
    Cited by others 6    

Recommend this journal

 

Fosfocin